Use Code: ND30 And Get 30% OFF | Get Free Delivery With No Minimum Order

Frequently bought together
METAZ 30GM CREAM
- Sku : I-003817
Key features
METAZ 30GM CREAM is a topical cream containing mometasone furoate 0.10%. It is a topical glucocorticoid that binds intracellular glucocorticoid receptors and modulates gene transcription to suppress inflammatory mediators, including inhibition of phospholipase A2 and reduced prostaglandin and leukotriene production, producing anti-inflammatory, antipruritic and vasoconstrictive effects. It is indicated for the relief of inflammatory and pruritic manifestations of steroid‑responsive dermatoses such as eczema, psoriasis and contact dermatitis. Available as a prescription 30 g cream.- Brand: METAZ
- Active Ingredient: MOMETASONE FUROATE
- Strength: 0.10%
- Dosage Form: Cream
- Pack Size: 30 g
- Route: Topical
- Prescription Status: Prescription
- Therapeutic Class: Dermatological
- Pharmacological Group: Corticosteroids (Plain)
- Manufacturer: SPIMACO
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2405233715
- Shelf Life: 36 months
- Storage: store below 25°c
- Skin Condition: Eczema, Psoriasis, Allergic/Contact Dermatitis
- Steroid Potency: Potent
Frequently bought together
Dosage & Administration
Dosing by Condition
For corticosteroid-responsive dermatoses (including atopic dermatitis and psoriasis): apply a thin layer to affected areas once daily; reassess if not improved within ~2 weeks and avoid prolonged continuous use.
Maximum Dose
Apply a thin layer once daily; reassess if no improvement within ~2 weeks; avoid prolonged use on the face/intertriginous areas and in children (generally limit to short courses, e.g., ≤5 days on face/children unless specialist-directed).
Dose Adjustment Notes
Use the lowest effective amount for the shortest duration; once control is achieved, reduce frequency or discontinue; if HPA-axis suppression or significant adverse effects occur, withdraw, reduce frequency, or switch to a less potent steroid; use extra caution on face/flexures and avoid occlusion unless directed.
How to Take
Apply a thin layer to the affected skin once daily and rub in gently; wash hands before and after application (unless treating hands); avoid contact with eyes, mouth, and other mucous membranes; do not use on the face, groin, or axillae or under occlusion/airtight dressings unless directed by a prescriber; apply to affected areas only.
Side Effects
Common Side Effects
Application-site burning, stinging/tingling, pruritus, irritation/dryness; folliculitis/furunculosis; with prolonged or extensive use: skin atrophy, striae, telangiectasia.
Safety & Warnings
Contraindications
Hypersensitivity to mometasone furoate or excipients; untreated bacterial/viral/fungal/parasitic skin infections; skin tuberculosis; cutaneous syphilis; post-vaccination skin reactions; rosacea; perioral dermatitis; acne vulgaris.
Drug Interactions
Drug Interactions
No clinically significant interactions expected with normal topical use; caution with concurrent topical/systemic corticosteroids and with occlusion (increases systemic absorption).
Food Interaction
No restriction
Alcohol Interaction
Safe
Special Populations
Pregnancy
Caution
Breastfeeding
Caution
Kidney Impairment
No adjustment needed
Storage & Patient Advice
Missed Dose
Apply when remembered; if it is close to the next scheduled application, skip the missed dose and resume the regular schedule; do not apply extra to make up for a missed dose.
Monitoring Requirements
Monitor clinical response and local adverse effects (atrophy, striae, telangiectasia, irritation, secondary infection); in patients using large amounts, large surface areas, prolonged courses, in children, or under occlusion, periodically assess for HPA-axis suppression and consider growth monitoring in children on long-term/repeated courses.
Pharmacology
Mechanism of Action
Topical glucocorticoid: binds intracellular glucocorticoid receptors, alters gene transcription to suppress inflammatory cytokines and mediators (including via inhibition of phospholipase A2 and reduced prostaglandin/leukotriene production), producing anti-inflammatory, antipruritic, and vasoconstrictive effects.
Metabolism
Rapid, extensive hepatic metabolism (predominantly via CYP3A4) to inactive metabolites.
Protein Binding
Approximately 98-99% (systemic protein binding).
Product Information
Available Dosage Forms
Cream, Ointment, Lotion, Nasal spray (other manufacturers/formulations)
Skin Condition
Eczema, Psoriasis, Allergic/Contact Dermatitis
Steroid Potency
Potent
Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 12-06-2026
-1744229570.gif)













